Enimmune corporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 22.876 million compared to TWD 1.944 million a year ago. Operating loss was TWD 82.722 million compared to TWD 71.866 million a year ago. Net loss was TWD 74.453 million compared to TWD 56.645 million a year ago. Basic loss per share was TWD 1.4 compared to TWD 1.29 a year ago.